Literature DB >> 18755699

Utility of tissue characterization in apical hypertrophic cardiomyopathy diagnosis.

João Abecasis1, Raquel Dourado, Isabel Arroja, José Azevedo, Aniceto Silva.   

Abstract

A 60-year-old male with previous hypertension, left ventricle hypertrophy, and coronary artery disease was referred for stress echocardiography because of exertional chest pain. The electrocardiogram revealed deep T-wave inversion in the anterolateral leads. Contrast echocardiography was notable for an apical filling defect consistent with the apical form of hypertrophic cardiomyopathy. Cardiac magnetic resonance demonstrated the 'ace of spades' left ventricle cavity, confirming the diagnosis. Single photon emission computed tomography showed increased apical left ventricle tracer uptake. Velocity vector imaging study depicted lower than normal absolute maximal longitudinal tissue velocities. The apical longitudinal strain was negative without base to apex gradient. There were normal longitudinal strain values in the basal and mid myocardial segments (Figure 1). Apical hypertrophic cardiomyopathy is a rare condition occasionally missed by conventional echocardiographic studies. Intravenous contrast enhancement might improve diagnosis accuracy. Newer Doppler-based techniques allowing tissue characterization may complement contrast echocardiography in its diagnosis.

Entities:  

Mesh:

Year:  2008        PMID: 18755699     DOI: 10.1093/ejechocard/jen227

Source DB:  PubMed          Journal:  Eur J Echocardiogr        ISSN: 1532-2114


  2 in total

Review 1.  Multimodality imaging in apical hypertrophic cardiomyopathy.

Authors:  Rosario Parisi; Francesca Mirabella; Gioel Gabrio Secco; Rossella Fattori
Journal:  World J Cardiol       Date:  2014-09-26

2.  Differences of left ventricular systolic deformation in hypertensive patients with and without apical hypertrophic cardiomyopathy.

Authors:  Yu-Cheng Kao; Ming-Feng Lee; Chun-Tai Mao; Wei-Siang Chen; Ning-I Yang; Wen-Jin Cherng; Ming-Jui Hung
Journal:  Cardiovasc Ultrasound       Date:  2013-11-14       Impact factor: 2.062

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.